Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Predicta ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced the availability of its first Laboratory ...
Brian McKernan joins as CEO to further advance Predicta’s clinical impact, including its non-invasive diagnostic for Multiple Myeloma “It’s an honor to join Predicta and our strong team of leading ...
Predicta, the Brazilian company part of e.Bricks portfolio and RBS’s digital investment branch, announced a deal to buy Melt DSP. The deal establishes a new company: Predicta Melt. They will position ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results